Objective: To describe the experience in endovacular treatment of juxtarenal aortic occlusions. Methods: The clinical data of 14 patients with juxtarenal aortic occlusion admitted from March 2012 to November 2014 were retrospectively analyzed. Of the patients, 9 cases were male and 5 cases were female; ages ranged from 42 to 71 years; 8 cases presented with intermittent claudication, 5 cases manifested as rest pain, and one case had toe gangrene, and the course of disease ranged from one month to 72 months. All patients received covered stent implantation after thrombolysis via a multi–side-hole catheter. Results: Interventional procedures were successfully completed in all patients. The thrombi in the abdominal aorta disappeared after catheter-directed thrombolysis in all patients except two cases, in whom little mural thrombi remained. All patients received covered kissing stent placement, after which, their symptoms of limb ischemia were significantly relieved. Follow-up period ranged from one month to 26 months, with average of 14.8 months, and the patency rate was 78.6%. Conclusion: Thrombolytic therapy combined with covered stent placement is a safe and effective endovascular treatment method for juxtarenal aortic occlusion.